Contine Reading & Discuss→Silence Therapeutics CEO, Tony Sedgwick, was interviewed by Brr Media's Cameron Young over 3rd May 2012 announcement that Silence's agreement with partner Pfizer has been extended to develop one of its compounds containing Silence's AtuRNAi. A recording of the interview can be found here: http://www.brrmedia.com/event/97871/anthony-sedgwick-ceo
Contine Reading & Discuss→On 18th April 2012, Silence Therapeutics' CEO Tony Sedgwick will present to the Private Investor Network, discussing the company overview and an introduction to RNAi. This free webcast event is open to all and Tony Sedgwick will be open to questions from participants. Tony Sedgwick will be speaking at 1.45pm...
Contine Reading & Discuss→